Cargando…

Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China

BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Xue, Li, Hai, Deng, Guohong, Wang, Xianbo, Zheng, Xin, Huang, Yan, Chen, Jinjun, Meng, Zhongji, Gao, Yanhang, Liu, Feng, Lu, Xiaobo, Shi, Yu, Zheng, Yubao, Yan, Huadong, Zhang, Weituo, Qiao, Liang, Gu, Wenyi, Zhang, Yan, Xiang, Xiaomei, Zhou, Yi, Sun, Shuning, Hou, Yixin, Zhang, Qun, Xiong, Yan, Zou, Congcong, Chen, Jun, Huang, Zebing, Li, Beiling, Jiang, Xiuhua, Zhong, Guotao, Wang, Haiyu, Chen, Yuanyuan, Luo, Sen, Gao, Na, Liu, Chunyan, Li, Jing, Li, Tao, Zheng, Rongjiong, Zhou, Xinyi, Ren, Haotang, Yuan, Wei, Qian, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761510/
https://www.ncbi.nlm.nih.gov/pubmed/35037228
http://dx.doi.org/10.1007/s12072-021-10282-8
_version_ 1784633542828883968
author Mei, Xue
Li, Hai
Deng, Guohong
Wang, Xianbo
Zheng, Xin
Huang, Yan
Chen, Jinjun
Meng, Zhongji
Gao, Yanhang
Liu, Feng
Lu, Xiaobo
Shi, Yu
Zheng, Yubao
Yan, Huadong
Zhang, Weituo
Qiao, Liang
Gu, Wenyi
Zhang, Yan
Xiang, Xiaomei
Zhou, Yi
Sun, Shuning
Hou, Yixin
Zhang, Qun
Xiong, Yan
Zou, Congcong
Chen, Jun
Huang, Zebing
Li, Beiling
Jiang, Xiuhua
Zhong, Guotao
Wang, Haiyu
Chen, Yuanyuan
Luo, Sen
Gao, Na
Liu, Chunyan
Li, Jing
Li, Tao
Zheng, Rongjiong
Zhou, Xinyi
Ren, Haotang
Yuan, Wei
Qian, Zhiping
author_facet Mei, Xue
Li, Hai
Deng, Guohong
Wang, Xianbo
Zheng, Xin
Huang, Yan
Chen, Jinjun
Meng, Zhongji
Gao, Yanhang
Liu, Feng
Lu, Xiaobo
Shi, Yu
Zheng, Yubao
Yan, Huadong
Zhang, Weituo
Qiao, Liang
Gu, Wenyi
Zhang, Yan
Xiang, Xiaomei
Zhou, Yi
Sun, Shuning
Hou, Yixin
Zhang, Qun
Xiong, Yan
Zou, Congcong
Chen, Jun
Huang, Zebing
Li, Beiling
Jiang, Xiuhua
Zhong, Guotao
Wang, Haiyu
Chen, Yuanyuan
Luo, Sen
Gao, Na
Liu, Chunyan
Li, Jing
Li, Tao
Zheng, Rongjiong
Zhou, Xinyi
Ren, Haotang
Yuan, Wei
Qian, Zhiping
author_sort Mei, Xue
collection PubMed
description BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We prospectively collected the data of 3970 patients with AoCLD from the CATCH-LIFE cohort in China. The prevalence of different Na levels (≤ 120; 120–135; 135–145; > 145) and their relationship with 90-day prognosis were analyzed. For hyponatremic patients, we measured Na levels on days 4 and 7 and compared their characteristics, based on whether hyponatremia was corrected. RESULTS: A total of 3880 patients were involved; 712 of those developed adverse outcomes within 90 days. There were 80 (2.06%) hypernatremic, 28 (0.72%) severe hyponatremic, and 813 (20.95%) mild hyponatremic patients at admission. After adjusting for all confounding factors, the risk of 90-day adverse outcomes decreased by 5% (odds ratio [OR] 0.95; 95% confidence interval [CI] 0.93–0.97; p < 0.001), 24% (OR 0.76; 95% CI 0.70–0.84; p < 0.001), and 42% (OR 0.58; 95% CI 0.49–0.70; p < 0.001) as Na level increased by 1, 5, and 10 mmol/L, respectively. Noncorrection of hyponatremia on days 4 and 7 was associated with 2.05-fold (hazard ratio [HR], 2.05; 95% CI, 1.50–2.79; p < 0.001) and 1.46-fold (HR 1.46; 95% CI 1.05–2.02; p = 0.028) higher risk of adverse outcomes. CONCLUSIONS: Hyponatremia was an independent risk factor for a poor 90-day prognosis in patients with AoCLD. Failure to correct hyponatremia in a week after admission was often associated with increased mortality. (ClinicalTrials.gov number: NCT02457637, NCT03641872). CLINICAL TRIAL NUMBERS: This study is registered at Shanghai www.clinicaltrials.org (NCT02457637 and NCT03641872). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-021-10282-8.
format Online
Article
Text
id pubmed-8761510
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-87615102022-01-18 Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China Mei, Xue Li, Hai Deng, Guohong Wang, Xianbo Zheng, Xin Huang, Yan Chen, Jinjun Meng, Zhongji Gao, Yanhang Liu, Feng Lu, Xiaobo Shi, Yu Zheng, Yubao Yan, Huadong Zhang, Weituo Qiao, Liang Gu, Wenyi Zhang, Yan Xiang, Xiaomei Zhou, Yi Sun, Shuning Hou, Yixin Zhang, Qun Xiong, Yan Zou, Congcong Chen, Jun Huang, Zebing Li, Beiling Jiang, Xiuhua Zhong, Guotao Wang, Haiyu Chen, Yuanyuan Luo, Sen Gao, Na Liu, Chunyan Li, Jing Li, Tao Zheng, Rongjiong Zhou, Xinyi Ren, Haotang Yuan, Wei Qian, Zhiping Hepatol Int Original Article BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We prospectively collected the data of 3970 patients with AoCLD from the CATCH-LIFE cohort in China. The prevalence of different Na levels (≤ 120; 120–135; 135–145; > 145) and their relationship with 90-day prognosis were analyzed. For hyponatremic patients, we measured Na levels on days 4 and 7 and compared their characteristics, based on whether hyponatremia was corrected. RESULTS: A total of 3880 patients were involved; 712 of those developed adverse outcomes within 90 days. There were 80 (2.06%) hypernatremic, 28 (0.72%) severe hyponatremic, and 813 (20.95%) mild hyponatremic patients at admission. After adjusting for all confounding factors, the risk of 90-day adverse outcomes decreased by 5% (odds ratio [OR] 0.95; 95% confidence interval [CI] 0.93–0.97; p < 0.001), 24% (OR 0.76; 95% CI 0.70–0.84; p < 0.001), and 42% (OR 0.58; 95% CI 0.49–0.70; p < 0.001) as Na level increased by 1, 5, and 10 mmol/L, respectively. Noncorrection of hyponatremia on days 4 and 7 was associated with 2.05-fold (hazard ratio [HR], 2.05; 95% CI, 1.50–2.79; p < 0.001) and 1.46-fold (HR 1.46; 95% CI 1.05–2.02; p = 0.028) higher risk of adverse outcomes. CONCLUSIONS: Hyponatremia was an independent risk factor for a poor 90-day prognosis in patients with AoCLD. Failure to correct hyponatremia in a week after admission was often associated with increased mortality. (ClinicalTrials.gov number: NCT02457637, NCT03641872). CLINICAL TRIAL NUMBERS: This study is registered at Shanghai www.clinicaltrials.org (NCT02457637 and NCT03641872). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-021-10282-8. Springer India 2022-01-17 /pmc/articles/PMC8761510/ /pubmed/35037228 http://dx.doi.org/10.1007/s12072-021-10282-8 Text en © Asian Pacific Association for the Study of the Liver 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Mei, Xue
Li, Hai
Deng, Guohong
Wang, Xianbo
Zheng, Xin
Huang, Yan
Chen, Jinjun
Meng, Zhongji
Gao, Yanhang
Liu, Feng
Lu, Xiaobo
Shi, Yu
Zheng, Yubao
Yan, Huadong
Zhang, Weituo
Qiao, Liang
Gu, Wenyi
Zhang, Yan
Xiang, Xiaomei
Zhou, Yi
Sun, Shuning
Hou, Yixin
Zhang, Qun
Xiong, Yan
Zou, Congcong
Chen, Jun
Huang, Zebing
Li, Beiling
Jiang, Xiuhua
Zhong, Guotao
Wang, Haiyu
Chen, Yuanyuan
Luo, Sen
Gao, Na
Liu, Chunyan
Li, Jing
Li, Tao
Zheng, Rongjiong
Zhou, Xinyi
Ren, Haotang
Yuan, Wei
Qian, Zhiping
Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title_full Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title_fullStr Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title_full_unstemmed Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title_short Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
title_sort prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761510/
https://www.ncbi.nlm.nih.gov/pubmed/35037228
http://dx.doi.org/10.1007/s12072-021-10282-8
work_keys_str_mv AT meixue prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT lihai prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT dengguohong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT wangxianbo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhengxin prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT huangyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT chenjinjun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT mengzhongji prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT gaoyanhang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT liufeng prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT luxiaobo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT shiyu prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhengyubao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT yanhuadong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhangweituo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT qiaoliang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT guwenyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhangyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT xiangxiaomei prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhouyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT sunshuning prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT houyixin prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhangqun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT xiongyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zoucongcong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT chenjun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT huangzebing prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT libeiling prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT jiangxiuhua prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhongguotao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT wanghaiyu prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT chenyuanyuan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT luosen prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT gaona prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT liuchunyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT lijing prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT litao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhengrongjiong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT zhouxinyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT renhaotang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT yuanwei prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina
AT qianzhiping prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina